Showing results (31-40 of 126) with videos related to
Sort By:
Pageof 13
Statistical Applications in Genetics and Molecular Biology|October 24, 2012
A modified maximum contrast method for unequal sample sizes in pharmacogenomic studiesKengo Nagashima, Yasunori Sato, Chikuma HamadaComputational and Mathematical Methods in Medicine|July 7, 2015
Enhancing the Lasso Approach for Developing a Survival Prediction Model Based on Gene Expression DataShuhei Kaneko, Akihiro Hirakawa, Chikuma HamadaJournal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma HamadaBiometrical Journal. Biometrische Zeitschrift|April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectivesToshifumi Sugitani, Toshimitsu Hamasaki, Chikuma HamadaNeuroepidemiology|October 2, 2004
Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: an updated analysis of incubation timeShigeyuki Matsui, Tetsuji Sadaike, Chikuma Hamada, et al.Chemotherapy|August 18, 2017
The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the LungMasahiro Tsuboi, Chikuma Hamada, Harubumi Kato, et al.Anticancer Research|October 7, 2017
A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive CancerTakanori Tanase, Chikuma Hamada, Takayuki Yoshino, et al.Statistics in Medicine|July 16, 2013
An efficient and robust method for analyzing population pharmacokinetic data in genome-wide pharmacogenomic studies: a generalized estimating equation approachKengo Nagashima, Yasunori Sato, Hisashi Noma, et al.Journal of Biopharmaceutical Statistics|February 9, 2018
Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trialsFumiya Shimamura, Chikuma Hamada, Shigeyuki Matsui, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|February 27, 2007
Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and/or flutter monitored with trans-telephonic electrocardiography: a multicenter, placebo-controlled, double-blind trialHirotsugu Atarashi, Satoshi Ogawa, Hiroshi Inoue, et al.Pageof 13